Drug development for chronic cancers: Time to think differently? Journal Article
| Author: | Spriggs, D. R. |
| Article Title: | Drug development for chronic cancers: Time to think differently? |
| Keywords: | cancer chemotherapy; cancer survival; bevacizumab; doxorubicin; solid tumor; gemcitabine; paclitaxel; cancer patient; topotecan; ovarian neoplasms; progression free survival; ovary cancer; neoplasm recurrence, local; peritoneal neoplasms; editorial; chronic disease; fallopian tube neoplasms; trabectedin; polyethylene glycols; genetic heterogeneity; epothilones; epothilone b; olaparib; neoplasms, glandular and epithelial; randomized controlled trial (topic); phase 3 clinical trial (topic); treosulfan; canfosfamide |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 31 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-11-01 |
| Start Page: | 3779 |
| End Page: | 3780 |
| Language: | English |
| DOI: | 10.1200/jco.2012.42.3269 |
| PROVIDER: | scopus |
| PUBMED: | 22987092 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 3 December 2012" - "CODEN: JCOND" - "Source: Scopus" |
